A composite T cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events
Year: 2022
Type: article
Source: Cancer Cell
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4221038102
